Cargando…

A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma

Indoleamine 2,3-dioxygenase 1 (IDO1) activity links to immune escape of cancers. Inhibition of IDO1 provides a new approach for cancer treatment. Most clinical IDO1 drugs show marginal efficacy as single agents. On basis of molecular docking and pharmacophore modelling, a novel inhibitor Roxyl-WL wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Guangwei, Wang, Tianqi, Li, Yongtao, Huang, Zhi, Wang, Xin, Zheng, Jianyu, Yang, Shengyong, Fan, Yan, Xiang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022239/ https://www.ncbi.nlm.nih.gov/pubmed/29932010 http://dx.doi.org/10.1080/14756366.2018.1471688

Ejemplares similares

The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1
por: Flick, Hollie E., et al.
Publicado: (2013)

Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control
por: Wang, Xin, et al.
Publicado: (2020)

Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
por: Ge, Shushan, et al.
Publicado: (2020)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
por: Marttila, Saara, et al.
Publicado: (2011)

The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma
por: Jia, Huijie, et al.
Publicado: (2018)

INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
por: Yue, Eddy W., et al.
Publicado: (2017)

Identification of the Key Enzymes in WL Gum Biosynthesis and Critical Composition in Viscosity Control
por: Li, Hui, et al.
Publicado: (2022)

Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling
por: Huang, Zhi, et al.
Publicado: (2018)

Rho_T Production via W_L Z_L Fusion at Hadronic Colliders
por: Azuelos, Georges, et al.
Publicado: (1999)

IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma
por: Liu, Hongmei, et al.
Publicado: (2022)

(68)Ga-HBED-CC-WL-12 PET in Diagnosing and Differentiating Pancreatic Cancers in Murine Models
por: Xiang, Qiying, et al.
Publicado: (2023)

Assessment of the Biocontrol Potential of Bacillus velezensis WL–23 against Kiwifruit Canker Caused by Pseudomonas syringae pv. actinidiae
por: Wang, Bingce, et al.
Publicado: (2023)

Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy
por: Wang, Zhiren, et al.
Publicado: (2023)

The preparation and characterization of a novel sphingan WL from marine Sphingomonas sp. WG
por: Li, Hui, et al.
Publicado: (2016)

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
por: Zakharia, Yousef, et al.
Publicado: (2021)

Trial watch: IDO inhibitors in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
por: Li, Yueshan, et al.
Publicado: (2022)

Hybrid Histidine Kinase WelA of Sphingomonas sp. WG Contributes to WL Gum Biosynthesis and Motility
por: Li, Hui, et al.
Publicado: (2022)

Bacillus megaterium WL-3 Lipopeptides Collaborate Against Phytophthora infestans to Control Potato Late Blight and Promote Potato Plant Growth
por: Wang, Youyou, et al.
Publicado: (2020)

M. tuberculosis Induces Potent Activation of IDO-1, but This Is Not Essential for the Immunological Control of Infection
por: Blumenthal, Antje, et al.
Publicado: (2012)

Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant
por: de Souza, Gabriela Alves, et al.
Publicado: (2019)

High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
por: Messaoud, Mariem, et al.
Publicado: (2021)

CD4 responses against IDO
por: Andersen, Mads Hald
Publicado: (2012)

Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors
por: Zhang, Qing-Wen, et al.
Publicado: (2018)

Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor-κB Activation
por: Lin, Tzu-Hung, et al.
Publicado: (2013)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
por: Zhang, Rongjie, et al.
Publicado: (2022)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

Novel Anthraquinone-based Derivatives as Potent Inhibitors for Receptor Tyrosine Kinases
por: Stasevych, M., et al.
Publicado: (2015)

A potent endocytosis inhibitor Ikarugamycin up-regulates TNF production
por: Minamidate, Ai, et al.
Publicado: (2021)

Identification and optimisation of next generation inhibitors of IDO1 and TDO
por: Wise, Alan, et al.
Publicado: (2015)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

Run 265 - 22 GeV/c - 4 bunches - WL 2C22 - R1
por: Vos, L
Publicado: (1972)

Development of [(18)F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
por: Lesniak, Wojciech G., et al.
Publicado: (2019)

Physicochemical and Structural Characterization of Alkali-Treated Biopolymer Sphingan WL Gum from Marine Sphingomonas sp. WG
por: Lin, Jieying, et al.
Publicado: (2023)

Discovery of 12O—A Novel Oral Multi-Kinase Inhibitor for the Treatment of Solid Tumor
por: Fan, Yan, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitors for in-transit melanoma
por: Nan Tie, Emilia, et al.
Publicado: (2020)

The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
por: Orecchini, E, et al.
Publicado: (2023)

Repurposing Ponatinib as a Potent Agent against KIT Mutant Melanomas
por: Han, Yong, et al.
Publicado: (2019)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
por: Mao, Long-fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ilkpgd9vda4d5pkb6tveaukkfq